Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability

Muscle and Nerve

Volumn 26, Issue 5, 2002, Pages 702-707

  Vernino, Steven ^a   Lennon, Vanda A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmunity; Encephalopathy; Fasciculations; Neuromyotonia; Thymoma

Indexed keywords

ANTIBODY; ION CHANNEL; NICOTINIC RECEPTOR; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FASCICULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; MYOKYMIA; NERVE EXCITABILITY; NEUROMUSCULAR DISEASE; NEUROMUSCULAR HYPEREXCITABILITY; PATHOGENESIS; PRIORITY JOURNAL;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; HUMANS; ION CHANNELS; ISAACS SYNDROME; MOTOR NEURONS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, NICOTINIC;

EID: 0036843065     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10266     Document Type: Article

References (23)

1. Ansevin C, Agamanolis D. Rippling muscles and myasthenia gravis with rippling muscles. Arch Neurol 1996;53:197-199.
2. Arimura K, Watanabe O, Kitajima I, Suehara M, Minato S, Sonoda Y, Higuchi I, Takenaga S, Maruyama I, Osame M. Antibodies to potassium channels of PC12 in serum of Isaacs' syndrome: Western blot and immunohistochemical studies. Muscle Nerve 1997;20:299-305.
3. Auger RG. AAEM Minimonograph #44: Diseases associated with excess motor unit activity. Muscle Nerve 1994;17:1250-1263.
4. + channel antibodies. Neurology 2000;54:771-772.
5. Chan KH, Vernino S, Lennon VA. ANNA-3 anti-neuronal nuclear antibody: Marker of lung cancer-related autoimmunity. Ann Neurol 2001;50:301-311.
6. Dropcho E. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis. Ann Neurol 1996;39:659-667.
7. + channel antibody syndrome. Neurology 2001;57:1707-1708.
8. + channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-246.
9. Lee EK, Maselli RA, Ellis WG, Agius MA. Morvan's fibrillary chorea: A paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry 1998;65:857-862.
10. Lennon VA, Manley HA, Kim K-K, Parisi JE, Kilimann MW, Benarroch EE. Amphiphysin autoantibodies: A paraneoplastic serological marker of breast and lung cancer-related encephalomyeloradiculoneuritides but not classical stiffman syndrome. Neurology 1997;48(suppl 2):A434.
11. Ligouri R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, Baruzzi A, Carey T, Gambetti P, Lugaresi E, Montagna P. Morvan's syndrome: Peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001;124:2417-2426.
12. Newsom-Davis J. Autoimmune neuromyotonia (Isaacs' syndrome): An antibody-mediated potassium channelopathy. Ann NY Acad Sci 1997;835:111-119.
13. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome): Report of five cases and literature review. Brain 1993;116:453-469.
14. Riche G, Trouillas P, Bady B. Improvement of Isaacs' syndrome after treatment with azathioprine. J Neurol Neurosurg Psychiatry 1995;59:448.
15. Ricker K, Moxley R, Rohkamm R. Rippling muscle disease. Arch Neurol 1989;46:405-408.
16. Stephan D, Buist N, Chittenden A, Ricker K, Zhou J, Hoffman E. A rippling muscle disease gene is localized to 1q41: Evidence for multiple genes. Neurology 1994;44:1915-1920.
17. Tahmoush A, Alonso R, Tahmoush G, Heiman-Patterson T. Cramp-fasciculation syndrome: A treatable hyperexcitable peripheral nerve disorder. Neurology 1991;41:1021-1024.
18. Vernino S, Adamski J, Kryzer TJ, Fealey RD, Lennon VA. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 1998;50:1806-1813.
19. Vernino S, Auger RG, Emslie-Smith AM, Harper CM, Lennon VA. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology 1999; 53:1233-1239.
20. Vernino S, Kryzer T, Lennon V. Autoantibodies in autoimmune autonomic neuropathies and neuromuscular hyperexcitability disorders. In: Rose N, Hamilton R, Detrick B, editors. Manual of Clinical Laboratory Immunology, 6th Ed. Washington, DC: ASM Press; 2002. p 1013-1017.
21. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000; 343:847-855.
22. Walker GR, Watkins T, Ansevin CF. Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognize skeletal muscle proteins: Possible relationship of antigens and stretch-activated ion channels. Biochem Biophys Res Commun 1999;264:430-435.
23. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001;49:146-154.